Shopping Cart
- Remove All
- Your shopping cart is currently empty
Emtricitabine, a potent nucleoside reverse transcriptase inhibitor, is employed for managing HIV infection. Emtricitabine S-oxide, also known as Emtricitabine sulfoxide, represents a significant degradation byproduct of Emtricitabine.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $123 | 35 days | |
10 mg | $950 | 35 days |
Description | Emtricitabine, a potent nucleoside reverse transcriptase inhibitor, is employed for managing HIV infection. Emtricitabine S-oxide, also known as Emtricitabine sulfoxide, represents a significant degradation byproduct of Emtricitabine. |
In vitro | Emtricitabine, an antiretroviral agent, undergoes degradation under various stress conditions—acidic, basic, and oxidative—resulting in over 51%, 13%, and 53% degradation respectively, and yielding three major degradation products (Degradant-I to Degradant-III). This process aligns with ICH guidelines to elucidate degradation pathways and identify degradation products of emtricitabine. |
Alias | Emtricitabine sulfoxide, Emtricitabine Degradant-III |
Molecular Weight | 263.25 |
Formula | C8H10FN3O4S |
Cas No. | 152128-77-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.